Skip to main navigation
  • About Us
    • Our Living Values
    • Senior Management
    • Board of Directors
    • Collaborations
    • Corporate Compliance & Ethics
    • Corporate Responsibility
    • Contact Us
  • Pipeline
    • Lorigerlimab (PD-1 × CTLA-4)
    • MGC026 (B7-H3 ADC)
    • MGC028 (ADAM9 ADC)
    • MGD024 (CD123 × CD3)
  • Technology
    • Platforms
    • CDMO Capabilities
    • Publications
  • Patients
    • Clinical Trials
    • Expanded Access
    • Resources
  • Investors

    Investor Relations

    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Senior Management
      • Board of Directors
      • Committee Composition
      • Contact the Board
      • Charters and Documents
    • Financials & Filings
      • SEC Filings
      • Quarterly Results
      • Key Metrics
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Analyst Coverage
      • Ownership Profile
    • Investor FAQs
    • Publications
    • Contact Investor Relations
  • Join Our Team
    • Current Openings
    • Employee Benefits

Financials & Filings

Shareholder Tools


  • Facebook
  • LinkedIn
  • Twitter
  • RSS

Breadcrumb

Home Investors Financials & Filings

Financials & Filings

Show all

2025

Q3
  • MacroGenics Reports Third Quarter 2025 Financial Results and Provides Update on Corporate Progress
  • Form 10-Q

PROXY STATEMENTS

Filing date View
Apr 11, 2025 View HTML
0001125345-25-000048.pdf
0001125345-25-000048.xls
Apr 11, 2025 View HTML
0001125345-25-000047.pdf
0001125345-25-000047.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

FORM 10-K

Filing date View
Mar 9, 2026 View HTML
0001125345-26-000017.pdf
0001125345-26-000017.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Mar 20, 2025 View HTML
0001125345-25-000042.pdf
0001125345-25-000042.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

FORM 10-Q

Filing date View
Nov 12, 2025 View HTML
0001125345-25-000108.pdf
0001125345-25-000108.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Aug 14, 2025 View HTML
0001125345-25-000101.pdf
0001125345-25-000101.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
    • About Us
    • Our Living Values
    • Senior Management
    • Board of Directors
    • Collaborations
    • Corporate Compliance & Ethics
    • Corporate Responsibility
    • Contact Us
    • Pipeline
    • Lorigerlimab (PD-1 × CTLA-4)
    • MGC026 (B7-H3 ADC)
    • MGC028 (ADAM9 ADC)
    • MGD024 (CD123 × CD3)
    • Technology
    • Platforms
    • Capabilities
    • Publications
    • Patients
    • Clinical Trials
    • Expanded Access
    • Resources
    • Investors
    • Footer investor menu

      • Press Releases
      • Events & Presentations
      • Corporate Governance
      • Financials & Filings
      • Stock Information
      • Investor FAQs
      • Publications
      • Contact Us
    • Join Our Team
    • Current Openings
    • Employee Benefits
©2026 MacroGenics, Inc.
  • Contact Us
  • Site Map
  • Privacy Policy
  • Terms of Use
  • Other Notices